Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company that discovers and develops novel cancer vaccines, announced today the pricing of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE